HR. 9077In Committee
To direct the Director of the National Institutes of Health and the Secretary of Health and Human Services to evaluate hormone variability and hormone testing, respectively, in women with respect to perimenopause.
Impact Score
37
Limited
Momentum
90
Accelerating
Summary
Directs NIH and HHS to evaluate hormone variability and hormone testing in women during perimenopause
What this does
- Require hormone testing evaluation
- Direct hormone variability evaluation
Latest action
2026-05-29 — Referred to the House Committee on Energy and Commerce.